Challenges in the Pharmacogenomic Annotation of Whole Genomes

Next‐generation sequencing technologies have enabled the sequencing of an entire genome for less than $4,000. With access to all the genetic variation in an individual, our task will be to use this information to assess the genetic influences on drug efficacy, toxicity, and dosage. Clinical Pharmaco...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical pharmacology and therapeutics 2013-08, Vol.94 (2), p.211-213
Hauptverfasser: Altman, R B, Whirl-Carrillo, M, Klein, T E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Next‐generation sequencing technologies have enabled the sequencing of an entire genome for less than $4,000. With access to all the genetic variation in an individual, our task will be to use this information to assess the genetic influences on drug efficacy, toxicity, and dosage. Clinical Pharmacology & Therapeutics (2013); 94 2, 211–213. doi:10.1038/clpt.2013.111
ISSN:0009-9236
1532-6535
DOI:10.1038/clpt.2013.111